Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance

Go back to Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 14.40 +0.06 (0.42%)
Previous Close $14.34    52 Week High $12.48 
Open $14.17    52 Week Low $1.60 
Day High $14.47    P/E N/A 
Day Low $13.95    EPS $-6.33 
Volume 1,424,655